In conclusion, in a NSCLC cellular model system, we identified three clusters of co-expressed genes whose expression correlates with resistance to EGFR-TKI and/or intermediate EMT phenotypes. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.